QbD Group
    Clinical Literature Review – Common Gaps and Hurdles to Take

    Clinical Literature Review – Common Gaps and Hurdles to Take

    In this blogpost, we are sharing our experience on the common gaps and hurdles that manufacturers are facing when undertaking this Systematic Literature Review (SOTA).

    2023年6月18日1 分钟阅读

    How can we assist in consolidated SOTA literature reviews?

    The SOTA literature review, as part of the clinical evaluation process, is a time-consuming complex process that requires specific reading, writing, and strong analytical skills.

    At QbD Clinical, we provide knowledge-based expertise to help you set out the clinical strategy and plan and document the clinical evaluation process throughout the journey of your medical device – from start to finish.

    To speed up the preparation of the required documentation and ensure high quality deliverables, a team of regulatory affairs specialists, literature review experts, medical writers, medical advisors and project managers work closely together.

    Take advantage of the multi-disciplinary expertise of QbD Clinical to speed up and deliver an MDR compliant SOTA literature review and clinical evaluation in an efficient way.

    Our services at a glance:

    • Gap analysis of SOTA literature review and clinical evaluation documents
    • Systematic literature reviews – literature review plan and report
    • Regulatory Medical Writing – CEP, CER, PMS plan and report, PMCF plan and report, PSUR
    • Clinical medical writing – CIP and CIR
    • Advise in clinical strategy
    • Operational management of pre-and post-market clinical investigations and PMCF surveys

    For help with any of the above, QbD Clinical can provide a solution. Our medical writers are determined to go the extra mile to serve your needs. Don’t hesitate to contact us.

    Clinical

    Clinical Solutions services

    Accelerate Your Clinical Programs

    End-to-end clinical trial management from strategy to submission for medical devices, IVD, and pharmaceuticals.

    Read more
    分享本文

    订阅生命科学领域的最新动态

    专家观点直达您的收件箱——选择您的兴趣。

    绝无垃圾邮件。随时取消订阅。

    Keep reading

    Related articles